SCHEMBL1758987

SCHEMBL1758987

CC(c1ccccc1)[C@@](C(=O)O)(c1ccccc1F)N(C)C

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
KCNN4 O15554 5/20 0.39
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
KCNE1 P15382 1/20 0.35
KCNQ1 P51787 1/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
ALOX5 P09917 1/20 0.34
MTOR P42345 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
OPRK1 P41145 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1315351 1.00 MEN1 (0.46) MEN1KMT2AKCNN4AKR1C3AKR1C2
SCHEMBL304619 1.00 MEN1 (0.46) MEN1KMT2AKCNN4AKR1C3AKR1C2
SCHEMBL305198 1.00 MEN1 (0.46) MEN1KMT2AKCNN4AKR1C3AKR1C2
SCHEMBL6673967 0.69 KDM4E (0.41) ALDH1A1GAAALOX5MTORL3MBTL1
SCHEMBL1316741 0.69 GAA (0.38) MEN1KMT2AKCNN4ALDH1A1GAA
SCHEMBL1316739 0.69 GAA (0.38) MEN1KMT2AKCNN4ALDH1A1GAA
SCHEMBL2089215 0.67 CYP1A2 (0.52) KMT2AKCNN4ALDH1A1OPRK1
SCHEMBL30501782 0.67 KCNN4 (0.50) KMT2AKCNN4AKR1C3AKR1C2KCNE1
SCHEMBL1239901 0.67 KCNN4 (0.50) KMT2AKCNN4AKR1C3AKR1C2KCNE1
SCHEMBL23357274 0.66 CYP2D6 (0.44) KMT2AALDH1A1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075439-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-06-23 WO disclosed
WO-2011059850-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed
WO-2011059887-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 WO disclosed